Publish date:

Bristol-Myers: Analysts' Upgrades, Downgrades

BMY is upgraded at Goldman to buy. Company has a solid showing at ASCO and has a robust pipeline.
Author:

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Abbott Laboratories

(ABT) - Get Report

downgraded at Goldman from Buy to Neutral. $59 price target. Valuation call, as BMY appears more attractive in the near term.

Ann Taylor

(ANN)

upgraded at Goldman to Buy. $25 price target. Sales finally appear to be turning around.

Bristol-Myers

(BMY) - Get Report

upgraded at Goldman to Buy. $30 price target. Company has a solid showing at ASCO and has a robust pipeline.

Celgene

(CELG) - Get Report

upgraded at Jefferies from Hold to Buy. $63 price target. Stock is down 18% since March, and the company is seeing good feedback from ASCO.

Chico's FAS

(CHS) - Get Report

downgraded at Goldman to Sell. Business turnaround appears to be leveling off. $10 price target.

Stocks Under $5 Top 10 Buy-Rated Stocks Under $5

Cisco Systems

(CSCO) - Get Report

upgraded at Auriga from Hold to Buy. $27 price target. Estimates also boosted, as the company appears positioned well in datacenter.

Dun & Bradstreet

(DNB)

initiated at Piper Jaffray. Initiated with a Neutral rating and $80 price target. Introduces 2010 EPS estimates of $5.50.

Brinker International

(EAT) - Get Report

downgraded at Morgan Stanley from Equal-weight to Underweight. Estimates also cut, as lower-priced casual dining restaurants could lag peers in a recovery. $17 price target.

Imax

TST Recommends

(IMAX) - Get Report

upgraded at Morgan Joseph to Buy. $21 price target. Valuation call, as theater growth should accelerate.

Intuit

(INTU) - Get Report

rated new Buy at UBS. $43 price target. Company is seeing renewed growth momentum.

National Oilweill Varco

(NOV) - Get Report

upgraded at Credit Suisse to Outperform from Neutral on improving floating rid orders. Price target trimmed by a dollar to $49.

Tyco Electronics

(TEL) - Get Report

downgraded at Ticonderoga from Buy to Neutral. Consumer-oriented portfolio has higher potential downside risk in the coming quarters.

STOCK COMMENTS / EPS CHANGES

Autodesk

(ADSK) - Get Report

cut from Conviction Buy List at Goldman. $35 price target. Stock may struggle, given higher fears of macro deceleration.

Ford

(F) - Get Report

estimates higher at Credit Suisse. 2010, 2011, and 2012 EPS estimates increased to $1.13, 1.22, and $1.33, respectively. Maintain Underperform rating and $10 price target.

First Solar

(FSLR) - Get Report

price target trimmed at Barclays. FSLR price target cut to $126 from $150. Currency weakness offset by better than expected fundamentals. Maintain Equal Weight rating.

Navistar

(NAV) - Get Report

estimates, target raised at Goldman. Shares of NAV now seen reaching $55. Estimates also increased, as orders have seen a sharp recovery over the past two months. Neutral rating.

Nasdaq

I:IXIC

estimates increased at Goldman through 2012. Company is buying back stock faster than expected. Buy rating.

Occidental Petroleum

(OXY) - Get Report

target upped at Collins Stewart. Shares of OXY now seen reaching $91. Company should generate better production growth, while keeping a lid on costs. Hold rating.

This article was written by a staff member of TheStreet.com.